It's official: Aragon spin-out Seragon launches
This article was originally published in Scrip
Executive Summary
Aragon Pharmaceuticals spin-out Seragon Pharmaceuticals announced its launch and an undisclosed Series A funding round on 20 August – a day after Johnson & Johnson said it completed the $650 million acquisition of Seragon's predecessor.